Evidence map›Paper›PMID 29776954›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Role of Elevated

Vladimir Bezrookove, Mehdi Nosrati, James R Miller, David De Semir, Altaf A Dar, Elham Vosoughi, Edith Vaquero, Antje Sucker, Alexander J Lazar, Jeffrey E Gershenwald and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Vladimir BezrookoveCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
Mehdi NosratiCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
James R MillerCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
David De SemirCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
Altaf A DarCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
Elham VosoughiCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.
Edith VaqueroCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.ORCID 0000-0003-0634-6064
Antje SuckerDepartment of Dermatology, University of Duisburg-Essen, Essen, Germany, and German Cancer Consortium, Heidelberg, Germany.
Alexander J LazarDepartments of Pathology, Genomic Medicine, Dermatology & Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jeffrey E GershenwaldDepartments of Pathology, Genomic Medicine, Dermatology & Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael A DaviesDepartments of Pathology, Genomic Medicine, Dermatology & Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Dirk SchadendorfDepartment of Dermatology, University of Duisburg-Essen, Essen, Germany, and German Cancer Consortium, Heidelberg, Germany.
Mohammed Kashani-SabetCenter for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California. kashani@cpmcri.org.
California Pacific Medical Center · USThe University of Texas MD Anderson Cancer Center · USWest German Heart and Vascular Center Essen · DE

Funding

UT M.D. Anderson Cancer Center SPORE in MelanomaP50CA093459 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GRIMM, ELIZABETH A · 2004 to 2014
$23.7M
PHIP as a Biomarker of Triple-Negative MelanomaR01CA175768 · NCI · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI KASHANI-SABET, MOHAMMED · 2014 to 2017
$1.7M
NCI NIH HHS P50 CA093459NCI NIH HHS R01 CA175768
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PrognosisAgedBiomarkers, TumorCutaneous Malignant MelanomaDisease-Free SurvivalDisease ProgressionDNA Copy Number VariationsFemaleGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsMaleMelanomaMiddle AgedNeoplasm MetastasisSkin NeoplasmsBiomarkers, TumorIntracellular Signaling Peptides and ProteinsPHIP protein, human

Identifiers

PMID29776954
PMCPMC6125189
OpenAlexW2804758127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.